SPIB and neoplasm: Through physical interaction with co‐factor SPIB, SPI1 exerted tumour‐promoting functions in glycolytic process and progression of cancer (Figure 8G), shedding light on the SPIB/SPI1‐mediated positive interplay loop of cancer cells and neutrophils as a therapeutic target against cancers.